Skip to main content

Livforsakringsbolaget Skandia, Omsesidigt

Position in NBIX — Neurocrine Biosciences Inc

CIK 1547926 Stockholm, V7

Position in NBIX

as of Jun 30, 2026 · filed Aug 18, 2026
Position Value
$3,117,990
+$2,986,250 QoQ
Shares Held
18,500
+1750.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#259
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Livforsakringsbolaget Skandia, Omsesidigt holds $23,022,407 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (13.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
18,500 $3,117,990

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,117,990 18,500
2026-03-31 $131,740 1,000
2025-12-31 $141,830 1,000
2025-09-30 $140,380 1,000
2025-06-30 $125,690 1,000
2025-03-31 $110,600 1,000
2024-12-31 $136,500 1,000
2024-09-30 $437,836 3,800
2024-06-30 $413,010 3,000
2024-03-31 $413,760 3,000
2023-12-31 $395,280 3,000
2023-09-30 $213,750 1,900
2023-06-30 $179,170 1,900
2023-03-31 $192,318 1,900
2022-12-31 $226,936 1,900
2022-09-30 $201,799 1,900
2022-06-30 $243,700 2,500
2022-03-31 $271,875 2,900
2021-12-31 $246,993 2,900
2021-09-30 $115,092 1,200
2021-06-30 $116,784 1,200
2021-03-31 $116,700 1,200
2020-12-31 $115,020 1,200
2020-09-30 $115,392 1,200
2020-06-30 $146,400 1,200
2020-03-31 $60,585 700